Coagulation and endothelial dysfunction during longterm hyperdynamic porcine bacteremia--effects of selective inducible nitric oxide synthase inhibition
Language English Country Germany Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
17264961
PII: 07020304
Knihovny.cz E-resources
- MeSH
- Acid-Base Equilibrium drug effects MeSH
- Bacteremia blood metabolism microbiology physiopathology MeSH
- Time Factors MeSH
- Endothelium, Vascular drug effects metabolism physiopathology MeSH
- Fibrinogen drug effects MeSH
- Blood Coagulation drug effects MeSH
- Enzyme Inhibitors pharmacology MeSH
- Cardiovascular System drug effects MeSH
- Lysine analogs & derivatives pharmacology MeSH
- Disease Models, Animal MeSH
- Nitric Oxide metabolism MeSH
- Oxidative Stress drug effects MeSH
- Swine MeSH
- Pseudomonas Infections blood metabolism microbiology physiopathology MeSH
- Pseudomonas aeruginosa MeSH
- Nitric Oxide Synthase Type II antagonists & inhibitors metabolism MeSH
- Animals MeSH
- Check Tag
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Fibrinogen MeSH
- Enzyme Inhibitors MeSH
- Lysine MeSH
- N(6)-(1-iminoethyl)lysine MeSH Browser
- Nos2 protein, rat MeSH Browser
- Nitric Oxide MeSH
- Nitric Oxide Synthase Type II MeSH
Coagulation abnormalities have been implicated in the pathogenesis of sepsis and organ dysfunction. Nitric oxide (NO) is regarded as a critical mediator of many vascular pathologies, including sepsis. However, limited evidence is available to document a relationship between NO generated by inducible NO synthase (iNOS) and hemostatic abnormalities in sepsis. Therefore, we evaluated the effects of selective iNOS inhibition on markers of endothelial and coagulation homeostasis in a clinically relevant model of porcine bacteremia induced and maintained for 24 hours (h) with a continuous infusion of live P. aeruginosa. After 12 h of sepsis, animals received either vehicle (Control, n=7) or continuous infusion of selective iNOS inhibitor L-NIL (n=7). Before as well as 12, 18 and 24 h after starting P. aeruginosa following variables related to i) endothelial dysfunction (von Willebrand factor [vWf]; tissue plasminogen activator activity [t-PA]; ii) coagulation (thrombin-antithrombin complexes [TAT]; platelet count); iii) fibrinolysis (t-PA activity, activity of plasminogen activator inhibitor type 1 (PAI-1 act); and iv) oxidative/nitrosative stress (isoprostanes, nitrate/nitrite levels) were measured. L-NIL inhibited sepsis-induced increase in plasma nitrate/nitrite and isoprostanes concentrations, prevented hypotension and acidosis. L-NIL significantly attenuated sepsis-induced rise in plasma vWF and TAT. P. aeruginosa-induced drop in t-PA activity was blunted by iNOS inhibition, while increased PAI-1 and reduced platelet count were not reversed by the treatment. In conclusion, selective iNOS inhibition was associated with attenuation of sepsis-induced coagulation and endothelial dysfunction suggesting the interplay between mediators of vascular system and hemostatic balance. Reduction of oxidative stress probably contributes to the beneficial effects afforded by iNOS blockade.